Agache I, Beltran J, Akdis C, Akdis M, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab,
mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. Allergy 2020 Feb 8. doi: 10.1111/all.14221.
PMID: 32034960